Nuformix (LSE:NFX) Deferred Tax : £0.00 Mil (TTM As of Sep. 2022)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Nuformix's change in deferred tax for the six months ended in Sep. 2022 was £0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Sep. 2022 was £0.00 Mil.

Nuformix Deferred Tax Historical Data

The historical data trend for Nuformix's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Deferred Tax Chart

Nuformix Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Deferred Tax

Get a 7-Day Free Trial

-0.13

-0.18

-0.17

-0.12

-0.16

Nuformix Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23
Deferred Tax	Get a 7-Day Free Trial									-	-	-0.16	-	-

Nuformix Deferred Tax Calculation

Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

Nuformix Deferred Tax Related Terms

Thank you for viewing the detailed overview of Nuformix's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix (LSE:NFX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Deferred Tax

Comparable Companies

Traded in Other Exchanges

1RT:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.